TrialJournal of diabetes science and technology2015

Safe and Effective Use of the Once Weekly Dulaglutide Single-Dose Pen in Injection-Naïve Patients With Type 2 Diabetes.

Glenn Matfin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.